Average Insider

Where insiders trade, we follow

Eikon Therapeutics, Inc. ($EIKN)
Accession: 0001193125-26-041549
Feb 6, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$13.29
Current$14.0217.8% above low, 82.2% below high
52W High$17.40

Filing Information

Accession Number0001193125-26-041549
Form Type4
Filing DateFeb 6, 2026
Document DateFeb 4, 2026
DocumentView SEC Filing
Transactions
15
Total Shares
48,445,027
Total Value
$4,999,968.00
P&L
-22.1% ($1,105,548.48)

Transactions

NameTitleSecurityDerivativeTransaction DateTypeSharesPriceTotal CostShares AfterDirect/IndirectNature of OwnershipActions
Wolfe Josh
Director
Common Stock
โ€”Feb 4, 2026Purchase138,888$18.00$2,499,984.00138,888IndirectSee footnoteView Details
Wolfe Josh
Director
Common Stock
โ€”Feb 4, 2026Purchase138,888$18.00$2,499,984.00138,888IndirectSee footnoteView Details
Wolfe Josh
Director
Common Stock
โ€”Feb 6, 2026Conversion2,387,705โ€”โ€”2,387,705IndirectSee footnoteView Details
Wolfe Josh
Director
Common Stock
โ€”Feb 6, 2026Conversion1,151,540โ€”โ€”1,290,428IndirectSee footnoteView Details
Wolfe Josh
Director
Common Stock
โ€”Feb 6, 2026Conversion2,155,765โ€”โ€”2,294,653IndirectSee footnoteView Details
Wolfe Josh
Director
Series A Preferred Stock
(Common Stock)
DerivativeFeb 6, 2026Conversion10,000,000โ€”โ€”0IndirectSee footnoteView Details
Wolfe Josh
Director
Series A-1 Preferred Stock
(Common Stock)
DerivativeFeb 6, 2026Conversion7,807,026โ€”โ€”0IndirectSee footnoteView Details
Wolfe Josh
Director
Series A-1 Preferred Stock
(Common Stock)
DerivativeFeb 6, 2026Conversion2,502,252โ€”โ€”0IndirectSee footnoteView Details
Wolfe Josh
Director
Series B Preferred Stock
(Common Stock)
DerivativeFeb 6, 2026Conversion796,380โ€”โ€”0IndirectSee footnoteView Details
Wolfe Josh
Director
Series B Preferred Stock
(Common Stock)
DerivativeFeb 6, 2026Conversion530,920โ€”โ€”0IndirectSee footnoteView Details
Wolfe Josh
Director
Series B-1 Preferred Stock
(Common Stock)
DerivativeFeb 6, 2026Conversion5,289,322โ€”โ€”0IndirectSee footnoteView Details
Wolfe Josh
Director
Series B-1 Preferred Stock
(Common Stock)
DerivativeFeb 6, 2026Conversion3,526,215โ€”โ€”0IndirectSee footnoteView Details
Wolfe Josh
Director
Series C Preferred Stock
(Common Stock)
DerivativeFeb 6, 2026Conversion303,360โ€”โ€”0IndirectSee footnoteView Details
Wolfe Josh
Director
Series C-1 Preferred Stock
(Common Stock)
DerivativeFeb 6, 2026Conversion1,450,614โ€”โ€”0IndirectSee footnoteView Details
Wolfe Josh
Director
Series D Preferred Stock
(Common Stock)
DerivativeFeb 6, 2026Conversion10,266,152โ€”โ€”0IndirectSee footnoteView Details
Version: v26.3.33